SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-20-001249
Filing Date
2020-02-10
Accepted
2020-02-07 18:01:20
Documents
50
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT cvm_10q.htm 10-Q 837720
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF cvm_ex31.htm EX-31 26821
3 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE cvm_ex32.htm EX-32 7353
  Complete submission text file 0001654954-20-001249.txt   3107665

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT cvm-20191231.xml EX-101.INS 499352
5 XBRL TAXONOMY EXTENSION SCHEMA cvm-20191231.xsd EX-101.SCH 45095
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cvm-20191231_cal.xml EX-101.CAL 41116
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cvm-20191231_def.xml EX-101.DEF 59779
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cvm-20191231_lab.xml EX-101.LAB 250968
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cvm-20191231_pre.xml EX-101.PRE 172829
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

IRS No.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-11889 | Film No.: 20588718
SIC: 2836 Biological Products, (No Diagnostic Substances)